Skip to main content
letter
. 2022 Jan 13;17(3):929–934. doi: 10.1007/s11739-021-02895-6

Table 2.

Evaluation of possible risk factors associated with the most prevalent symptoms

Fatigue Dyspnoea Anxiety or Depression Muscle or Join Pain Concentration problems
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value

Gender

 Men (ref)

 Women

4.65

(1.25–17.30)

0.02

6.01

(1.61–22.34)

 < 0.01

2.40

(0.70–8.20)

0.16

1.92

(0.60–6.20)

0.30

0.90

(0.30–2.30)

0.87
Age

0.98

(0.94–1.02)

0.31

0.97

(0.93–1.01)

0.20

0.97

(0.93–1.00)

0.12

0.96

(0.92–0.99)

0.03

0.95

(0.91–0.99)

0.04

Comorbidities

 None or 1 (ref)

 2 or more

1.60

(0.50–5.10)

0.42

2.78

(0.81–9.45)

0.10

3.64

(1.10–12.20)

0.04

1.40

(0.44–4.51)

0.57

2.30

(0.65–9.12)

0.09

Need for HFO or MV

 No (ref)

 Yes

2.40

(0.75–7.73)

0.14

3.36

(1.02–11.14)

0.05

0.75

(0.25–2.30)

0.61

0.98

(0.31–3.02)

0.97

0.72

(0.23–2.20)

0.56

Most prevalent symptoms were considered those that occupied the first places when order by frequency

A regression logistic model was used for calculation of OR 95% CI. MV (mechanical ventilation, including non-invasive and invasive mechanical ventilation); HFO (high-flow oxygen)